Dear Partners and Friends,
Following our successful participation in WHX Dubai 2026, we are excited to share our latest global milestones. To better serve our diverse markets, we have clearly organized our lineup into Wellness and Medical Device solutions.
1. Optimized Product Lineup
We are focusing on two distinct paths to ensure both retail accessibility and clinical precision:
HAGOBOGO (Wellness Line): Designed for the broad consumer market. Following our success in 7-Eleven and Olive Young, we are proud to announce our recent launch in Matsumotokiyoshi (Japan) this March.
HAGOBOGO Pro (Medical Device Line): Our premium model has officially secured CE IVDR (Europe), Medical Device Class I (Korea/Japan) and Class A (India) certifications. It delivers 98% accurate AI analysis in under 5 minutes for both professional and home-care use.
2. Rapid Global Expansion
Building on our foundation in Korea, Japan and the USA, we are expanding into Canada, Singapore, Sri Lanka and Malaysia in the first half of 2026.
As we finalize the first-batch production for the Pro (Medical Device) model, we are prioritizing partners on a first-come, first-served basis. This is a prime opportunity to lead the AI-driven fertility market before it reaches saturation.
3. Meet Us at KIMES 2026 (Booth G500)
Continuing our global tour from MEDICA, CES and WHX, we will be at KIMES 2026 (Seoul).
Location: Booth G500
Invitation: If you plan to attend, please let us know. We would love to schedule a brief meeting to discuss regional exclusivity or initial allocation volumes.
4. Advanced AI Reporting & Clinical "Bridge"
The HAGOBOGO app acts as a digital "Bridge," allowing users to export detailed data on sperm concentration and motility directly to healthcare providers. This creates seamless referral opportunities within your local medical networks.
We are ready to provide our Product Catalog and Price List for both HAGOBOGO and HAGOBOGO PRO upon request.
We look forward to a successful 2026 together.
